Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. [electronic resource] by
- Culig, Z
- Hoffmann, J
- Erdel, M
- Eder, I E
- Hobisch, A
- Hittmair, A
- Bartsch, G
- Utermann, G
- Schneider, M R
- Parczyk, K
- Klocker, H
Producer: 19990928
In:
British journal of cancer vol. 81
Availability: No items available.
|
|
19.
|
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. [electronic resource] by
- Cronauer, M V
- Hittmair, A
- Eder, I E
- Hobisch, A
- Culig, Z
- Ramoner, R
- Zhang, J
- Bartsch, G
- Reissigl, A
- Radmayr, C
- Thurnher, M
- Klocker, H
Producer: 19970627
In:
The Prostate vol. 31
Availability: No items available.
|
|
20.
|
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. [electronic resource] by
- Culig, Z
- Hobisch, A
- Herold, M
- Hittmair, A
- Thurnher, M
- Eder, I E
- Cronauer, M V
- Rieser, C
- Ramoner, R
- Bartsch, G
- Klocker, H
- Konwalinka, G
Producer: 19981103
In:
British journal of cancer vol. 78
Availability: No items available.
|